Feeding tolerance of a formula for premature infants versus donor breast milk in the first two weeks of life: a randomized not-inferiority trial
Phase 3
Completed
- Conditions
- eonatology
- Registration Number
- JPRN-UMIN000013922
- Lead Sponsor
- Romagnoli Costantino
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
congenital surgical disease, major malformation syndromes, abnormal prenatal Doppler velocimetry (AED and ARED), sepsis in the first 72 hours of life.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms by which donor breast milk improves feeding tolerance in preterm infants compared to formula?
How does the nutritional composition of the formula in JPRN-UMIN000013922 compare to standard donor breast milk in neonatal care?
Are there specific biomarkers that indicate which preterm infants would benefit more from formula or donor breast milk?
What adverse gastrointestinal events are associated with formula feeding in preterm infants versus donor breast milk?
What are the long-term developmental outcomes of preterm infants fed with specialized formula versus donor breast milk in clinical trials?